Lithium Therapy Guidelines

Pre-Treatment Evaluation

A complete medical history and physical examination should be performed to rule out any conditions that might affect lithium metabolism or increase risk of toxicity, as recommended by the American Academy of Child and Adolescent Psychiatry and the American Psychiatric Association 1, 2
Baseline assessments should include renal function tests, thyroid function tests, electrolyte tests, urinalysis, and a pregnancy test for females of reproductive age, as recommended by the American Academy of Child and Adolescent Psychiatry and the American Academy of Sleep Medicine 3
Patients with a personal or family history of medullary thyroid cancer, pregnancy, or inability to comply with monitoring should be cautious when using lithium due to potential risks, as noted by the American Psychiatric Association and FDA guidelines 4

Serum lithium levels should be monitored twice weekly until stabilized in the acute phase, and every 2-3 months in the maintenance phase, with samples drawn 12 hours after the last dose when lithium concentrations are relatively stable, as recommended by the American Psychiatric Association 5
The target range for serum lithium levels is 0.6-0.8 mmol/L for standard formulations, which typically requires 300 mg three to four times daily of lithium carbonate, with dosage adjustments necessary for elderly patients and those with renal impairment 5, 6
Elderly patients often require lower doses due to decreased clearance, and if using extended-release formulations, target serum concentrations should be in the upper range, as noted by the American Psychiatric Association and FDA guidelines 2, 5

Alcohol consumption should be completely avoided in patients taking lithium due to increased risk of lithium toxicity and potential for dangerous drug interactions, as recommended by the American Heart Association/American College of Cardiology guidelines and the American Academy of Child and Adolescent Psychiatry 7, 8
Patients should be explicitly warned about the risks of alcohol consumption while taking lithium and advised to completely abstain from alcohol, as noted by the American Academy of Child and Adolescent Psychiatry 7

Lithium maintenance therapy has been associated with fewer suicidal behaviors and deaths in patients with unipolar depression or bipolar disorder, with a suicide rate of 1.3 suicides per 1000 patient-years compared to approximately 5.5 suicides per 1000 patient-years in untreated depression, as recommended by the American Psychiatric Association 5
Low lithium levels are associated with higher relapse rates, and serum levels >1.5 mmol/L may have mild and reversible toxic effects, while levels >2.0 mmol/L may cause neurological symptoms, as noted by the American Psychiatric Association 5

Ongoing assessments should include monitoring of lithium levels, renal function, thyroid function, and urinalysis every 3-6 months, as recommended by the American Academy of Child and Adolescent Psychiatry and the American Academy of Sleep Medicine 4, 3
Medication non-adherence is the most common cause of low lithium levels, and a low lithium level in a patient taking lithium indicates inadequate therapeutic coverage, which may lead to treatment failure and symptom relapse, requiring dosage adjustment based on clinical response and monitoring, as noted by the American Psychiatric Association 9